CVR: 33058101
PHARMALAB ApS was a Danish company of the type Anpartsselskab based in Hårlev, founded in 2010 and dissolved in 2025. The company was registered under the industry Fremstilling af andre maskiner til generelle formål i.a.n.. In 2023, the company reported a gross profit of DKK -42,256 and a net result of DKK -31,505 compared with DKK -16,738 the year before. Equity amounted to DKK -107,589.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2023 | -42 t. | -32 t. | 165 t. | -108 t. | 1 | |
| 2022 | 9 t. | -17 t. | 999 t. | -76 t. | 1 | |
| 2021 | -17 t. | -24 t. | 196 t. | -59 t. | - | |
| 2020 | -10 t. | -8 t. | 17 t. | -35 t. | - | |
| 2019 | -28 t. | -23 t. | 31 t. | -27 t. | - | |
| 2018 | -138 t. | 286 t. | 16 t. | -5 t. | - | |
| 2017 | 8 t. | -22 t. | 251 t. | -291 t. | 0 | |
| 2016 | -198 t. | -216 t. | 241 t. | -269 t. | - | |
| 2015 | -135 t. | -148 t. | 174 t. | -54 t. | - | |
| 2014 | -57 t. | -46 t. | 113 t. | 94 t. | - |
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCompared to 180 companies in Fremstilling af andre maskiner til generelle formål i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of March 18, 2025, Lars Muhlig has left the board of directors of PHARMALAB ApS.
As of March 18, 2025, Jan Bojsen has left the board of directors of PHARMALAB ApS.
As of March 18, 2025, Jens Glavind has stepped down as chairman of PHARMALAB ApS.
As of March 18, 2025, Lars Muhlig has stepped down as director of PHARMALAB ApS.
As of March 18, 2025, Jan Bojsen has stepped down as director of PHARMALAB ApS.
PHARMALAB ApS was dissolved on March 18, 2025.
PHARMALAB ApS has published its annual report for 2023. Gross profit came to DKK -42,256, and the net result was DKK -31,505.
PHARMALAB ApS has published its annual report for 2022. Gross profit came to DKK 8,548, and the net result was DKK -16,738.
PHARMALAB ApS has published its annual report for 2021. Gross profit came to DKK -17,376, and the net result was DKK -23,848.
As of July 12, 2022, Cedra Godkendt Revisionsaktieselskab has stepped down as auditor of PHARMALAB ApS.
PHARMALAB ApS has published its annual report for 2020. Gross profit came to DKK -10,265, and the net result was DKK -8,054.
As of April 13, 2021, Lars Muhlig has joined the board of directors of PHARMALAB ApS.
As of April 13, 2021, Jan Bojsen has joined the board of directors of PHARMALAB ApS.
As of April 13, 2021, Jens Glavind is registered as chairman of PHARMALAB ApS.
As of April 13, 2021, Lars Muhlig is registered as director of PHARMALAB ApS.
PHARMALAB ApS has published its annual report for 2019. Gross profit came to DKK -28,250, and the net result was DKK -22,849.
PHARMALAB ApS has published its annual report for 2018. Gross profit came to DKK -138,224, and the net result was DKK 286,415.
As of December 27, 2018, Geo Allan Østergaard has stepped down as chairman of PHARMALAB ApS.
As of December 21, 2018, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of PHARMALAB ApS.
As of December 21, 2018, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of PHARMALAB ApS.
As of December 21, 2018, Lars Olofsson has left the board of directors of PHARMALAB ApS.
As of December 21, 2018, Michael Bøgeriis has left the board of directors of PHARMALAB ApS.
As of December 21, 2018, Michael Schiøtt Eliasen has left the board of directors of PHARMALAB ApS.
As of December 21, 2018, Ole Houg Larsen has left the board of directors of PHARMALAB ApS.
As of December 21, 2018, Jan Bojsen is registered as director of PHARMALAB ApS.
As of December 21, 2018, Lars Olofsson has stepped down as director of PHARMALAB ApS.
PHARMALAB ApS has published its annual report for 2017. Gross profit came to DKK 8,283, and the net result was DKK -21,650.
PHARMALAB ApS has published its annual report for 2016. Gross profit came to DKK -198,242, and the net result was DKK -215,628.
PHARMALAB ApS has published its annual report for 2015. Gross profit came to DKK -135,225, and the net result was DKK -148,216.
As of May 1, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of PHARMALAB ApS.
As of May 1, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of PHARMALAB ApS.
PHARMALAB ApS has published its annual report for 2014. Gross profit came to DKK -56,988, and the net result was DKK -46,325.
PHARMALAB ApS has published its interim report for the period July 1, 2012 – December 31, 2013.
As of January 17, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of PHARMALAB ApS.
As of January 17, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of PHARMALAB ApS.
As of March 31, 2012, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of PHARMALAB ApS.
As of March 31, 2012, VALLENSBÆK REVISION - REGISTRERET REVISONSAKTIESELSKAB has stepped down as auditor of PHARMALAB ApS.
As of March 7, 2012, Lars Olofsson is registered as director of PHARMALAB ApS.
As of March 7, 2012, Geo Allan Østergaard is registered as chairman of PHARMALAB ApS.
As of March 7, 2012, John Askholm has stepped down as chairman of PHARMALAB ApS.
As of March 7, 2012, Michael Schiøtt Eliasen has stepped down as director of PHARMALAB ApS.
As of July 2, 2010, VALLENSBÆK REVISION - REGISTRERET REVISONSAKTIESELSKAB has been appointed auditor of PHARMALAB ApS.
As of July 2, 2010, Lars Olofsson has joined the board of directors of PHARMALAB ApS.
As of July 2, 2010, Michael Bøgeriis has joined the board of directors of PHARMALAB ApS.
As of July 2, 2010, Michael Schiøtt Eliasen has joined the board of directors of PHARMALAB ApS.
As of July 2, 2010, Ole Houg Larsen has joined the board of directors of PHARMALAB ApS.
As of July 2, 2010, John Askholm is registered as chairman of PHARMALAB ApS.
As of July 2, 2010, Michael Schiøtt Eliasen is registered as director of PHARMALAB ApS.
PHARMALAB ApS was founded on July 2, 2010.